Aminoglycoside−Polyamine Library
A R T I C L E S
raphy from combinatorial libraries.17 Although the earliest
reports on the use of combinatorial synthesis of affinity ligands
involved screening of epitope peptide libraries,18-22 small-
molecule ligands have been identified for a variety of targets,
including kallikrien,23 IgG,24 and elastases25 from focused
libraries.
Previous work on parallel screening of commercially available
displacer candidates in our laboratory resulted in the identifica-
tion of aminoglycosides and linear polyamines as moderate- to
high-affinity displacers in cation-exchange systems.26,27 It was
therefore hypothesized that the derivatization of aminoglycosidic
core molecules with multiple copies of linear polyamines at
different positions on the core would result in multivalent
derivatives. Consequently, chemoenzymatic synthesis was used
to generate libraries based on polyamine derivatives of ami-
noglycosides. Enzymes were used to regioselectively acylate
aminoglycoside-linker derivatives, which were further modified
by linear polyamines at the selected positions. This enabled a
multivalent approach whereby linear polyamines were grafted
onto an aminoglycosidic core to generate multivalent cationic
molecules. The components of the library were screened for
their displacement efficacy using a batch displacement assay26
and for their DNA-binding efficacy using an ethidium bromide
displacement assay.35,36 The results presented in this paper
demonstrate that this approach can be successfully employed
to identify several powerful multivalent ligands for both protein
purification and DNA condensation.
We have recently developed a batch-displacement assay as
a high-throughput screening technique for the rapid identification
of potential displacer molecules.26 The screening results indi-
cated that a variety of aminoglycosides and linear polyamines
show moderate to high affinities as displacers in cation exchange
systems. The high-throughput screening technique is a powerful
route for the rapid identification of efficient displacer molecules
in ion-exchange systems, and it has been recently extended to
identify selective and high-affinity displacers for protein
mixtures.27 These HTS results have also been used to develop
quantitative structure-efficacy relationship (QSER) models,26
and they have been employed in concert with the multicom-
ponent steric mass action (SMA) formalism for the prediction
of chromatographic behavior of selected displacer leads.28
The complexation of DNA by polyamines has been investi-
gated in great detail.29-34 The addition of multivalent cations
with a charge greater than three in each molecule induces the
condensation of DNA in aqueous solutions. Multivalent cations
effectively reduce the electrostatic repulsion between DNA
molecules by charge neutralization, ultimately leading to DNA
collapse or condensation, which is an important first step for
gene therapy applications. Measurement of the ability of a drug
to displace ethidium bromide from DNA is established as a valid
measurement of its DNA binding ability. It is hypothesized that
DNA binding induced by polyamine binding above a critical
concentration causes conformational changes within the double
helix leading, to the release of bound ethidium bromide.35,36
In this paper, we describe the development of a small-
molecule library for potential use as both high-affinity displacers
in ion-exchange chromatography and as DNA-binding ligands.
Experimental Section
Materials. Candida antarctica lipase B (CAL-B, Novozyme 435)
was obtained from Novozymes North America, (Franklinton, NC) as
a gift. Pseudomonas fluorescence lipase (PFL) was purchased from
Amano (Nagoya, Japan). Fast Flow Sepharose SP (FF Sepharose SP),
High Performance SP Sepharose (HP Sepharose SP), and Source 15S
stationary phase materials were donated by Amersham Pharmacia
(Uppsala, Sweden). (Note that while the Sepharose materials are
agarose-based, the Source resins consist of hydrophilized poly(styrene-
divinylbenzene.) The HTS experiments were carried out using 96-well
Multiscreen, 0.45-µm Durapore membrane-bottomed plates donated by
Millipore. The 2′-deoxyadenosine, glucosamine, mannosamine, kana-
mycin A & B, neomycin sulfate, spermine, calf-thymus DNA, chicken
egg lysozyme, horse heart cytochrome-C, ammonium bicarbonate,
sodium phosphate (dibasic), and sodium phosphate (monobasic) were
purchased from Sigma (Saint Louis, MO). Ethylenediamine, diethyl-
enetriamine, vinyl chloroformate, and dry THF were purchased from
Aldrich (Milwaukee WI). Acetone-O-(vinyloxy)carbonyl)oxime was
prepared according to a literature protocol.37 Glucosamine analogues
(Scheme 1, molecules 1b-1e) neamine (Figure 2, molecule 15) and
methyl neobiosamine (Figure 2, molecule 18) were prepared according
to literature procedures.38-40
The 1H and 13C NMR spectra were recorded on a Varian spectrometer
with TMS as the internal standard. Chemical shifts are reported in ppm
and the coupling constants (J) are given in Hertz (Hz). The ESI-MS
and MALDI-TOF were measured on a Varian mass spectrometer. Flash
chromatography was performed on 60-200-mesh silica gel (Sigma
MO). Product yields, purities, and spectroscopic data are provided in
the Supporting Information section. Cation-exchange chromatography
was performed on Fast Flow Sepharose SP (FF Sepharose SP) using
ammonium bicarbonate (NH4HCO3) as a mobile phase. Fluorescence
and absorbance analyses were carried out using a Perkin-Elmer plate
reader and the results were analyzed using the software HTSoft 2.0.
Procedures. I. Generation of Glucosamine/Mannosamine Deriva-
tives (Scheme 1). Synthesis of Vinyl Carbamate Linkers, 2a-2e
(Procedure 1). Vinyl chloroformate (426 µL, 5.0 mmol) was added
(17) Lowe, C. R. Curr. Opin. Chem. Biol. 2001, 5, 248-256.
(18) Geysen, H. M.; Meleon, R. H.; Barteling, S. J. Proc. Natl. Acad. Sci. U.S.A.
1984, 81, 3998-4002.
(19) Scott, J. K.; Smith, G. P. Science 1990, 249, 386-390.
(20) Devlin, J. J.; Panganiban, L. C.; Devlin, P. E. Science 1990, 249, 404-
406.
(21) Barrett, R. W.; Cwirla, S. E.; Ackerman, M. S.; Olson, A. M.; Peters, E.
A.; Dower, W. J. Anal. Biochem. 1992, 204, 357-364.
(22) Oldenburg, K. R.; Loganathan, D.; Goldstein, I. J.; Schultz, P. G.; Gallop
M. A. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 5393-5397.
(23) Burton, N. P.; Lowe, C. R. J. Mol. Recognit. 1992, 5, 55-68.
(24) Rongxiu, L.; Victor, D.; Stewart, D. J.; Burton S, J.; Lowe C. R.; Nature
Biotechnol. 1998, 16, 190-195.
(25) Filippusson, H.; Erlendsson, L. S.; Lowe, C. R. J. Mol. Recognit. 2000,
13, 370-381.
(26) Mazza, C. B.; Rege, K.; Breneman, C. M.; Sukumar, N.; Dordick, J. S.;
Cramer, S. M. Biotechnol. Bioeng. 2002, 80, 60-73.
(27) Rege, K.; Ladiwala, A.; Tugcu, N.; Breneman, C.; Cramer, S. M. J.
Chromatogr., A 2004, 1033, 19-28.
(28) Rege, K.; Tugcu, N.; Cramer, S. M. Sep. Sci. Technol. 2003, 38, 1499-
1517.
(29) Saminathan, M.; Antony, T.; Shirahata, A.; Sigal, L H.; Thomas, T.;
Thomas, T. J. Biochemistry 1999, 38, 3821-3830.
(30) Deng, H.; Bloomfield, V. A.; Benevides, J. M.; Thomas, G. J., Jr. Nucleic
Acids Res. 2000, 28, 3379-3385.
(31) Vijayanathan, V.; Thresia, T.; Sriharata, A.; Thomas, T. J. Biochemistry
2001, 40, 13644-13651.
(32) Pelta, J.; Livolant, F.; Sikorav, J. L. J. Biol. Chem. 1996, 271, 5656-
5662.
(33) Basu, H. S. and Marton, L. J. Biochem. J. 1987, 244, 243-246.
(34) Raspaud, E.; Chaperon, I.; Leforestier, A.; Livolant, F. Biophys. J. 1999,
77, 1547-1555.
(37) Garc´ıa-Alles, L. F.; Magdalena, J.; Gotor, V. J. Org. Chem. 1996, 61, 6980-
6986.
(38) Shafizadeh, F.; Meshreki, M. H.; Susott, R. A. J. Org. Chem. 1973, 38,
1190-1194.
(35) Geall, A. J.; Blagbrough, I. S. J. Pharm. Biomed. Anal. 2000, 22, 849-
859.
(39) Gross, P. H.; Jeanloz, R. W. J. Org. Chem. 1967, 32, 2759-2763.
(40) Rinehart, K. L.; Argoudelis, A. D.; Goss, W. A.; Sohler, A.; Schaffner, C.
P. J. Am. Chem. Soc. 1996, 82, 3938-3946.
(36) Boger, D. L.; Brian, F. E.; Brunette, S. R.; Tse, W. C.; Hedrick, M. P. J.
Am. Chem. Soc. 2001, 123, 5878-5891.
9
J. AM. CHEM. SOC. VOL. 126, NO. 39, 2004 12307